[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @DCVaxDefender autologous assassin πΊπΈ π΄ββ οΈ autologous assassin πΊπΈ π΄ββ οΈ posts on X about $nwbo, $ibrx, $40b, approved the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1772690455387316225/interactions)  - X Week XXXXX +9.20% - X Month XXXXXX +80% - X Months XXXXXXX +550% ### Mentions: XX [#](/creator/twitter::1772690455387316225/posts_active)  - X Week XX -XXXX% - X Month XX +59% - X Months XXX +735% ### Followers: XXX [#](/creator/twitter::1772690455387316225/followers)  - X Week XXX +0.51% - X Month XXX +0.51% - X Months XXX +225% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1772690455387316225/influencer_rank)  ### Social Influence [#](/creator/twitter::1772690455387316225/influence) --- **Social category influence** [finance](/list/finance) XXX% [stocks](/list/stocks) XXXX% [technology brands](/list/technology-brands) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% [countries](/list/countries) XXXX% **Social topic influence** [$nwbo](/topic/$nwbo) #24, [$ibrx](/topic/$ibrx) #31, [$40b](/topic/$40b) #22, [approved](/topic/approved) #966, [os](/topic/os) 0.57%, [definitive](/topic/definitive) 0.57%, [protocol](/topic/protocol) 0.57%, [bluetooth](/topic/bluetooth) 0.57%, [$500kyear](/topic/$500kyear) 0.57%, [$12m](/topic/$12m) XXXX% **Top accounts mentioned or mentioned by** [@flemmingbruce](/creator/undefined) [@galzusresearch](/creator/undefined) [@tiggersdad2](/creator/undefined) [@northwestbio](/creator/undefined) [@anonymous275111](/creator/undefined) [@joeretired41](/creator/undefined) [@bohsie](/creator/undefined) [@andrewcaravello](/creator/undefined) [@cohenmilstein](/creator/undefined) [@mabbpah](/creator/undefined) [@justinkeister5](/creator/undefined) [@maveric92283613](/creator/undefined) [@neilmck37597308](/creator/undefined) [@dstock07734](/creator/undefined) [@dogedoj](/creator/undefined) [@metacollectiveg](/creator/undefined) [@hoffmann6383](/creator/undefined) [@matthewherper](/creator/undefined) [@jackndreu](/creator/undefined) [@doctorstock06](/creator/undefined) **Top assets mentioned** [ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx) [NVIDIA (NVIDIA)](/topic/$nvidia) [NVIDIA Corp. (NVDA)](/topic/$nvda) [Hundred Million (100M)](/topic/$100m) ### Top Social Posts [#](/creator/twitter::1772690455387316225/posts) --- Top posts by engagements in the last XX hours "You are leaning hard on a mechanistic narrative (macrophage activation) that's interesting but not clinically definitive. If there's a randomized OS advantage vs FOLFIRINOX link the peer-reviewed paper and the hazard ratios. Also: clarify whether benefits are from efficacy or tolerability. Do not sell mechanism as a substitute for hard survival data and if you are implying commercial impact then show the numbers in your 10-K" [X Link](https://x.com/DCVaxDefender/status/1978593184667066518) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-15T22:45Z XXX followers, XXX engagements "In addition cleanroom technicians. Unlikely they would expand payroll obligations without commercial demand for $NWBO DCVax" [X Link](https://x.com/DCVaxDefender/status/1978857369636405676) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-16T16:15Z XXX followers, XXX engagements "In the context of $NWBO and business practices you can absolutely share or license a codec a web standard a communications protocol because that's what lets markets form. MPEG HTML USB Wi-Fi Bluetooth HTTP Ethernet are all examples of shared frameworks that make commerce work. Those are like the roads everyone drives upon. You do not share or license away what gives you leverage over everyone else. Nobody hands over their crown jewels. Apple never shared iOS or the chips that power its ecosystem. Nvidia never shared CUDA as it's the backbone of their AI dominance. Mellanox did not give away" [X Link](https://x.com/DCVaxDefender/status/1977075126391722022) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-11T18:13Z XXX followers, XXX engagements "NICE rejecting vorasidenib = fantastic news. MHRA approved it but NICE just said no because it costs $500K/year on PFS no OS. Lifetime cost per patient $1-2M. With economies of scale thanks to Flaskworks $NWBO will cost a fraction. Ask yourself: Why would the NHS fund two glioma drugs when one actually saves lives and the other destroys single payer economics The answer seems obvious. In addition NICE came out with guidance one month after MHRA made their decision in September 2025. Given vorasidenib's February 2024 EMA acceptance then September 2025 MHRA approval could see MHRA decision on" [X Link](https://x.com/DCVaxDefender/status/1978881930222596441) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-16T17:53Z XXX followers, 1954 engagements "You can't compare these two filings. Vorasidenib doesn't have overall-survival data so NICE can't run a robust QALY model on it. The evidence package is weaker by definition vs $NWBO. DCVax-L on the other hand has overall-survival data and long-term follow-up in both newly diagnosed and recurrent GBM. That's not an apples-to-apples comparison rather it's a completely different level of evidence. So the review path will be different and that's a good thing" [X Link](https://x.com/DCVaxDefender/status/1978983297490522623) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-17T00:36Z XXX followers, XXX engagements "Both Michael Eisenkraft and Laura Posner are still listed as attorneys to be noticed in the $NWBO spoofing case. That means they're on the case. Under S.D.N.Y. Local Rule XXX an attorney cannot withdraw without court approval and a filed notice. No such filing exists. @NorthwestBio has a diverse legal team so not every attorney is active on every single motion. Claiming otherwise only weakens our position and helps manipulation. Stay focused on the facts" [X Link](https://x.com/DCVaxDefender/status/1979220993378865339) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-17T16:20Z XXX followers, 1557 engagements "Those who hype $IBRX Anktiva and dismiss $NWBO say that it activates natural killer cells. This is a meaningless claim without context into dendritic cells. Natural killer cells are part of the innate immune system. They are blunt instruments that can recognize some abnormal cells but they do not carry specific memory. They cannot be programmed to hunt down and eradicate a tumor in a durable way especially a cold tumor. The real power of the immune system against cancer is adaptive immunity. That requires antigen presentation. Cytotoxic T cells and helper T cells must be educated to recognize" [X Link](https://x.com/DCVaxDefender/status/1974262715674730679) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-03T23:58Z XXX followers, 2599 engagements "@hoffmann6383 @james5922551742 @nwbo $NWBO hitting a $40B market cap would not take years. $NVIDIA doubled its value in months after the P100 launch once investors grasped the scale of the breakthrough. DCVax is every bit that kind of shift so once the market gets it expect fast moves" [X Link](https://x.com/DCVaxDefender/status/1976363460138303793) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-09T19:05Z XXX followers, XXX engagements "@hoffmann6383 @james5922551742 @nwbo 2016 $NVDA doubled its market capitalization by $30B in a few months. Saying "$40B is a big number" implies $NWBO headwinds. Look at the $100M circular financing between OpenAI Oracle AMD NVidia. Markets are full of investors eager for return" [X Link](https://x.com/DCVaxDefender/status/1976369606722830793) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-09T19:30Z XXX followers, XXX engagements "$40B isn't a big number in biotech it's mid. This isn't 2005. If you think $NWBO needs a short squeeze to get there you do not understand how markets move when real fundamentals hit. If you find me annoying because I still believe in the company's value well I find you unimaginative and probably not much fun to hang around. π" [X Link](https://x.com/DCVaxDefender/status/1976394872195313844) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-09T21:10Z XXX followers, 1697 engagements "@JackNdreu Yes there was no way NWBO could be bought without consolidation" [X Link](https://x.com/DCVaxDefender/status/1976418357533606353) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-09T22:43Z XXX followers, XXX engagements "Dr Bosch π― $NWBO" [X Link](https://x.com/DCVaxDefender/status/1976467541175435393) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-10T01:59Z XXX followers, 1680 engagements "Yes you are directionally correct as a $NWBO buyout price establishes the floor and arbitrage pressure can absolutely trigger a short squeeze as funds institutions and traders pile in to close that gap. To be clear a squeeze is not required for this to work out. The fundamentals alone justify the valuation. We are talking about a company that has created an entirely new market which is a true scalable cure for cancer where none existed before. That's not speculative. That's real verifiable medical progress. So when people say "we can't get there" they're ignoring what this represents: a" [X Link](https://x.com/DCVaxDefender/status/1976475843003138477) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-10T02:32Z XXX followers, 1223 engagements "@maveric92283613 @newstart_2024 The FDA isn't the problem with $AMRN. The problem is the glorified fish oil wrapped in marketing. Blaming bureaucracy or regulators is lazy. The science was weak the concept was dumb and the market saw right through it. $IBRX has the same problem" [X Link](https://x.com/DCVaxDefender/status/1977733734091686124) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-13T13:50Z XXX followers, XXX engagements "@DrPatSoonShiong PASS-01 found similar PFS and only "trends" favoring Gem/nab-Pac. That's not validation it's parity. Theres no phase III evidence proving Abraxane + Gemcitabine beats FOLFIRINOX. $IBRX are a scam. $NWBO has actual PIII data in orphan cold tumor indications" [X Link](https://x.com/DCVaxDefender/status/1978594741789794754) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-15T22:52Z XXX followers, XXX engagements "NICE rejected Vorasidenib which was recently approved by MHRA. DCVax would be a far more cost effective option. Will @MHRAgovuk soon approve $NWBO" [X Link](https://x.com/DCVaxDefender/status/1978870476169506905) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-16T17:07Z XXX followers, 1001 engagements "@exosome Then hit it with some $NWBO" [X Link](https://x.com/DCVaxDefender/status/1978877455801762287) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-16T17:35Z XXX followers, XXX engagements "$NWBO built DCVax manufacturing in the UK. Once MHRA approval hits it's a revolutionary first-line therapy not a second-line adjunct like vorasidenib. That drug just delays progression it doesn't kill cancer. DCVax-L extends survival and eradicates tumor cells. One global validation will snowball approvals. NICE isn't where the real money is anyway rather that's the United States" [X Link](https://x.com/DCVaxDefender/status/1979000771011080588) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-17T01:45Z XXX followers, XXX engagements "@StonkMasterJ @ATLnsider The $NWBO NICE evidence package isn't just for the UK. It's the same ICER data insurers in the US will take for reimbursement models. If there's a buyout then that package becomes the blueprint for global pricing and payer negotiations. The upside here is enormous" [X Link](https://x.com/DCVaxDefender/status/1979001258598912120) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-17T01:47Z XXX followers, XXX engagements "Based on the vorasidenib timeline MHRA $NWBO approval is likely soon. NICE economic analysis has to happen but that work isn't just for the U.K. Every regulator uses the same global economic standards. The thresholds differ but the data are identical. What's being built now will drive reimbursement everywhere. It will be used by Northwest Biotherapeutics as an independent company or the new management if they tender an appropriate offer" [X Link](https://x.com/DCVaxDefender/status/1979009340737478905) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-17T02:19Z XXX followers, XXX engagements "@JackNdreu @Bigsky716 @StonkMasterJ @ATLnsider We get the best price in solidarity against a buyout" [X Link](https://x.com/DCVaxDefender/status/1979027096203637030) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-17T03:30Z XXX followers, XX engagements "Northwest Biotherapeutics are hiring GMP production scientists to work in Class A-D clean rooms. Closing date November 14th 2025. Good sign for $NWBO. Hopefully we get news soon" [X Link](https://x.com/DCVaxDefender/status/1978856892278407324) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-16T16:13Z XXX followers, 2579 engagements "$NWBO sold at $XX far too low for the first therapy to show a survival advantage in glioblastoma an orphan cold tumor indication. The global economic impact is enormous with patients living longer returning to work reducing healthcare costs and contributing to productivity. A true survival breakthrough for the most deadly cancer transforms not only medicine but national economies" [X Link](https://x.com/DCVaxDefender/status/1979013008643772774) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-17T02:34Z XXX followers, XXX engagements "New Orleans #NoKings Show up hungover then meet at the bar afterwards π" [X Link](https://x.com/DCVaxDefender/status/1979673634462675090) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-18T22:19Z XXX followers, XXX engagements "@realDonaldTrump pedophile @SpeakerJohnson groomer #NoKings" [X Link](https://x.com/DCVaxDefender/status/1979705151947690237) [@DCVaxDefender](/creator/x/DCVaxDefender) 2025-10-19T00:24Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
autologous assassin πΊπΈ π΄ββ οΈ posts on X about $nwbo, $ibrx, $40b, approved the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence finance XXX% stocks XXXX% technology brands XXXX% cryptocurrencies XXXX% countries XXXX%
Social topic influence $nwbo #24, $ibrx #31, $40b #22, approved #966, os 0.57%, definitive 0.57%, protocol 0.57%, bluetooth 0.57%, $500kyear 0.57%, $12m XXXX%
Top accounts mentioned or mentioned by @flemmingbruce @galzusresearch @tiggersdad2 @northwestbio @anonymous275111 @joeretired41 @bohsie @andrewcaravello @cohenmilstein @mabbpah @justinkeister5 @maveric92283613 @neilmck37597308 @dstock07734 @dogedoj @metacollectiveg @hoffmann6383 @matthewherper @jackndreu @doctorstock06
Top assets mentioned ImmunityBio, Inc. Common Stock (IBRX) NVIDIA (NVIDIA) NVIDIA Corp. (NVDA) Hundred Million (100M)
Top posts by engagements in the last XX hours
"You are leaning hard on a mechanistic narrative (macrophage activation) that's interesting but not clinically definitive. If there's a randomized OS advantage vs FOLFIRINOX link the peer-reviewed paper and the hazard ratios. Also: clarify whether benefits are from efficacy or tolerability. Do not sell mechanism as a substitute for hard survival data and if you are implying commercial impact then show the numbers in your 10-K"
X Link @DCVaxDefender 2025-10-15T22:45Z XXX followers, XXX engagements
"In addition cleanroom technicians. Unlikely they would expand payroll obligations without commercial demand for $NWBO DCVax"
X Link @DCVaxDefender 2025-10-16T16:15Z XXX followers, XXX engagements
"In the context of $NWBO and business practices you can absolutely share or license a codec a web standard a communications protocol because that's what lets markets form. MPEG HTML USB Wi-Fi Bluetooth HTTP Ethernet are all examples of shared frameworks that make commerce work. Those are like the roads everyone drives upon. You do not share or license away what gives you leverage over everyone else. Nobody hands over their crown jewels. Apple never shared iOS or the chips that power its ecosystem. Nvidia never shared CUDA as it's the backbone of their AI dominance. Mellanox did not give away"
X Link @DCVaxDefender 2025-10-11T18:13Z XXX followers, XXX engagements
"NICE rejecting vorasidenib = fantastic news. MHRA approved it but NICE just said no because it costs $500K/year on PFS no OS. Lifetime cost per patient $1-2M. With economies of scale thanks to Flaskworks $NWBO will cost a fraction. Ask yourself: Why would the NHS fund two glioma drugs when one actually saves lives and the other destroys single payer economics The answer seems obvious. In addition NICE came out with guidance one month after MHRA made their decision in September 2025. Given vorasidenib's February 2024 EMA acceptance then September 2025 MHRA approval could see MHRA decision on"
X Link @DCVaxDefender 2025-10-16T17:53Z XXX followers, 1954 engagements
"You can't compare these two filings. Vorasidenib doesn't have overall-survival data so NICE can't run a robust QALY model on it. The evidence package is weaker by definition vs $NWBO. DCVax-L on the other hand has overall-survival data and long-term follow-up in both newly diagnosed and recurrent GBM. That's not an apples-to-apples comparison rather it's a completely different level of evidence. So the review path will be different and that's a good thing"
X Link @DCVaxDefender 2025-10-17T00:36Z XXX followers, XXX engagements
"Both Michael Eisenkraft and Laura Posner are still listed as attorneys to be noticed in the $NWBO spoofing case. That means they're on the case. Under S.D.N.Y. Local Rule XXX an attorney cannot withdraw without court approval and a filed notice. No such filing exists. @NorthwestBio has a diverse legal team so not every attorney is active on every single motion. Claiming otherwise only weakens our position and helps manipulation. Stay focused on the facts"
X Link @DCVaxDefender 2025-10-17T16:20Z XXX followers, 1557 engagements
"Those who hype $IBRX Anktiva and dismiss $NWBO say that it activates natural killer cells. This is a meaningless claim without context into dendritic cells. Natural killer cells are part of the innate immune system. They are blunt instruments that can recognize some abnormal cells but they do not carry specific memory. They cannot be programmed to hunt down and eradicate a tumor in a durable way especially a cold tumor. The real power of the immune system against cancer is adaptive immunity. That requires antigen presentation. Cytotoxic T cells and helper T cells must be educated to recognize"
X Link @DCVaxDefender 2025-10-03T23:58Z XXX followers, 2599 engagements
"@hoffmann6383 @james5922551742 @nwbo $NWBO hitting a $40B market cap would not take years. $NVIDIA doubled its value in months after the P100 launch once investors grasped the scale of the breakthrough. DCVax is every bit that kind of shift so once the market gets it expect fast moves"
X Link @DCVaxDefender 2025-10-09T19:05Z XXX followers, XXX engagements
"@hoffmann6383 @james5922551742 @nwbo 2016 $NVDA doubled its market capitalization by $30B in a few months. Saying "$40B is a big number" implies $NWBO headwinds. Look at the $100M circular financing between OpenAI Oracle AMD NVidia. Markets are full of investors eager for return"
X Link @DCVaxDefender 2025-10-09T19:30Z XXX followers, XXX engagements
"$40B isn't a big number in biotech it's mid. This isn't 2005. If you think $NWBO needs a short squeeze to get there you do not understand how markets move when real fundamentals hit. If you find me annoying because I still believe in the company's value well I find you unimaginative and probably not much fun to hang around. π"
X Link @DCVaxDefender 2025-10-09T21:10Z XXX followers, 1697 engagements
"@JackNdreu Yes there was no way NWBO could be bought without consolidation"
X Link @DCVaxDefender 2025-10-09T22:43Z XXX followers, XXX engagements
"Dr Bosch π― $NWBO"
X Link @DCVaxDefender 2025-10-10T01:59Z XXX followers, 1680 engagements
"Yes you are directionally correct as a $NWBO buyout price establishes the floor and arbitrage pressure can absolutely trigger a short squeeze as funds institutions and traders pile in to close that gap. To be clear a squeeze is not required for this to work out. The fundamentals alone justify the valuation. We are talking about a company that has created an entirely new market which is a true scalable cure for cancer where none existed before. That's not speculative. That's real verifiable medical progress. So when people say "we can't get there" they're ignoring what this represents: a"
X Link @DCVaxDefender 2025-10-10T02:32Z XXX followers, 1223 engagements
"@maveric92283613 @newstart_2024 The FDA isn't the problem with $AMRN. The problem is the glorified fish oil wrapped in marketing. Blaming bureaucracy or regulators is lazy. The science was weak the concept was dumb and the market saw right through it. $IBRX has the same problem"
X Link @DCVaxDefender 2025-10-13T13:50Z XXX followers, XXX engagements
"@DrPatSoonShiong PASS-01 found similar PFS and only "trends" favoring Gem/nab-Pac. That's not validation it's parity. Theres no phase III evidence proving Abraxane + Gemcitabine beats FOLFIRINOX. $IBRX are a scam. $NWBO has actual PIII data in orphan cold tumor indications"
X Link @DCVaxDefender 2025-10-15T22:52Z XXX followers, XXX engagements
"NICE rejected Vorasidenib which was recently approved by MHRA. DCVax would be a far more cost effective option. Will @MHRAgovuk soon approve $NWBO"
X Link @DCVaxDefender 2025-10-16T17:07Z XXX followers, 1001 engagements
"@exosome Then hit it with some $NWBO"
X Link @DCVaxDefender 2025-10-16T17:35Z XXX followers, XXX engagements
"$NWBO built DCVax manufacturing in the UK. Once MHRA approval hits it's a revolutionary first-line therapy not a second-line adjunct like vorasidenib. That drug just delays progression it doesn't kill cancer. DCVax-L extends survival and eradicates tumor cells. One global validation will snowball approvals. NICE isn't where the real money is anyway rather that's the United States"
X Link @DCVaxDefender 2025-10-17T01:45Z XXX followers, XXX engagements
"@StonkMasterJ @ATLnsider The $NWBO NICE evidence package isn't just for the UK. It's the same ICER data insurers in the US will take for reimbursement models. If there's a buyout then that package becomes the blueprint for global pricing and payer negotiations. The upside here is enormous"
X Link @DCVaxDefender 2025-10-17T01:47Z XXX followers, XXX engagements
"Based on the vorasidenib timeline MHRA $NWBO approval is likely soon. NICE economic analysis has to happen but that work isn't just for the U.K. Every regulator uses the same global economic standards. The thresholds differ but the data are identical. What's being built now will drive reimbursement everywhere. It will be used by Northwest Biotherapeutics as an independent company or the new management if they tender an appropriate offer"
X Link @DCVaxDefender 2025-10-17T02:19Z XXX followers, XXX engagements
"@JackNdreu @Bigsky716 @StonkMasterJ @ATLnsider We get the best price in solidarity against a buyout"
X Link @DCVaxDefender 2025-10-17T03:30Z XXX followers, XX engagements
"Northwest Biotherapeutics are hiring GMP production scientists to work in Class A-D clean rooms. Closing date November 14th 2025. Good sign for $NWBO. Hopefully we get news soon"
X Link @DCVaxDefender 2025-10-16T16:13Z XXX followers, 2579 engagements
"$NWBO sold at $XX far too low for the first therapy to show a survival advantage in glioblastoma an orphan cold tumor indication. The global economic impact is enormous with patients living longer returning to work reducing healthcare costs and contributing to productivity. A true survival breakthrough for the most deadly cancer transforms not only medicine but national economies"
X Link @DCVaxDefender 2025-10-17T02:34Z XXX followers, XXX engagements
"New Orleans #NoKings Show up hungover then meet at the bar afterwards π"
X Link @DCVaxDefender 2025-10-18T22:19Z XXX followers, XXX engagements
"@realDonaldTrump pedophile @SpeakerJohnson groomer #NoKings"
X Link @DCVaxDefender 2025-10-19T00:24Z XXX followers, XX engagements
/creator/x::DCVaxDefender